Interesting facts
Exploring 2-amino-N1,N9-bis(3,10-diisopropyl-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl)-4,6-dimethyl-3-oxo-phenoxazine-1,9-dicarboxamide
This intriguing compound, 2-amino-N1,N9-bis(3,10-diisopropyl-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl)-4,6-dimethyl-3-oxo-phenoxazine-1,9-dicarboxamide, showcases the fascinating world of organic chemistry. Here are some noteworthy aspects:
- Complex Composition: The intricate structure reveals a high degree of molecular complexity, including multiple functional groups that contribute to its unique properties.
- Potential Applications: Compounds like this one can have diverse applications, particularly in the fields of pharmaceuticals, materials science, and dye chemistry due to their unique optical and chemical properties.
- Research Interest: This compound is a subject of ongoing research; its structure suggests potential for use in the development of advanced materials or therapeutic agents.
- Hierarchy of Functionality: The presence of both carboxamide and oxazine groups brings distinctive reactivity patterns that chemists can exploit in synthesis or material design.
- Intriguing Synthesis: The synthesis of such a compound involves various steps that require careful planning and execution, showcasing the beauty of modern organic synthesis techniques.
In conclusion, the exploration of 2-amino-N1,N9-bis(3,10-diisopropyl-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl)-4,6-dimethyl-3-oxo-phenoxazine-1,9-dicarboxamide provides a glimpse into the potential for innovative chemical applications and the creative approaches needed in its synthesis and manipulation. Such compounds remind us of the vastness of possibilities that exist in the realm of chemistry, encouraging researchers to delve deeper into understanding their characteristics and potential.
Synonyms
actinomycin D
50-76-0
Oncostatin K
Actinomycin Aiv
Dactinomycin D
Actinomycin 7
Cosmegen
Lyovac cosmegen
Acto-D
Dilactone actinomycindioic D acid
Actinomycin C(sub1)
Antibiotic from Streptomyces parvullus
Actinomycindioic D acid, dilactone
Actinomycin-(threo-val-pro-sar-meval)
X 97
2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide
GNF-PF-1977
D Actinomycin
HBF 386 meractinomycin
Actinomycin D from Streptomyces species
Dactinomycin (USP)
COSMEGEN (TN)
C62H86N12O16
NSC3053
-pentone
l-3-oxo-
Actinomycin D (JP18)
Actinomycin D deriv. of 3H-phenoxaocardazine
Neuro_000003
SCHEMBL6152
CBiol_002056
o)-(1-oxo-1,2-ethanediyl)]bis(N-methyl)L-valine
4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide
CHEMBL427947
MEGxm0_000350
ACon0_000471
ACon1_001004
AMD-3030-PI
BCBcMAP01_000155
CHEBI:125400
RJURFGZVJUQBHK-UHFFFAOYSA-N
Bio1_000342
Bio1_000831
Bio1_001320
HMS3267F05
HMS3394O17
HMS3872H13
1H-Pyrrolo(2,1-1)-(1,4,7,10,13)oxatetraazacyclohexadecine
HB1477
LMPK14000005
NSC191297
NSC684906
AKOS024456475
AD20776
NSC-191297
NSC-684906
SMP1_000005
NCGC00025059-02
NCGC00025059-03
NCGC00025059-04
NCGC00169767-01
NCGC00271789-11
2-Amino-(N,N)-1-bis(hexadecahydro-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1]-[1,4,7,10,13] oxatetraazacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide
AC-31936
NCI60_030539
NS00001367
C06770
D00214
Actinomycin D;Actactinomycin A IV;Actinomycin 7
BRD-A42383464-001-02-2
BRD-A42383464-001-05-5
BRD-A42383464-001-06-3
Actinomycin D deriv. of 1H-pyrrolo(2,1-1)(1,4,7,10,13)oxatetra-azacyclohexadecine
10,10'-[(2-Amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-Diyl)bis(carbonylimino)]bis-[dodecahydro-6,13-diisopropyl-2,5,9-trimethyl-1H-Pyrrolo-(2,1-1)(1,4,7,10,13)oxatetra-azacyclohexadecine]-1,4,7,11,14
2-Amino-N,N'-bis-[hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-1)(1,4,7,10,13)oxatetraazacyclohexadecin-10-yl]-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarb
2-Amino-N,N'-bis[hexadecahydro-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-1)(1,4,10,13)oxatetraazacyclohexadecin-10-yl]-
3H-phenoxazine-1,9-dicarboxamide, 2-amino-N,N'-bis[hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4,6-dimethy
Bis(XI-lactone)N,N'-[(2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-diyl)bis-[carbonylimino(3-hydroxy-1-oxobutylidene)imino(3-methyl-1-oxobutylidene)(tetrahydro-1H-pyrrole-1,2-diyl)carbonyl(methylimin
Solubility Overview
The solubility of the compound 2-amino-N1,N9-bis(3,10-diisopropyl-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl)-4,6-dimethyl-3-oxo-phenoxazine-1,9-dicarboxamide (C22H27N5O6) can be assessed through several considerations:
Factors Influencing Solubility
Solvent Compatibility
This compound is likely to exhibit variable solubility, being more soluble in:
In contrast, solubility in non-polar solvents may be limited due to the compound's functional groups.
General Conclusion
Given the elaborate structure of this compound, one can conclude that while it may show significant solubility in specific solvents, it is essential to consider its complexity for accurate predictions. Testing under various conditions will provide the most reliable insights into its solubility characteristics.